Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cells
暂无分享,去创建一个
N. Schmitz | W. Siegert | H. Einsele | A. Zander | J. Finke | D. Niederwieser | R. Blasczyk | T. Klingebiel | G. Ehninger | W. Ebell | E. Albert | R. Arnold | B. Hertenstein | H. Sayer | B. Kremens | D. Bunjes | S. Goldmann | M. Lindemann | H. Grosse-wilde | J. Casper | A. Heyll | U. Schaefer | T. Eiermann | J. Mytilineos | A. Fauser | B. Thiele | S. Ferenčík | V. Runde | R. Schwerdtfeger | S. Schröder | H. Kolb | D. Beelen | H. Ottinger | R. Schulze‐Rath | K. Kolbe | A. Knipper | C. Müller | E. Lenartz
[1] W R Mayr,et al. Nomenclature for factors of the HLA system, 2000. , 2001, Human immunology.
[2] X. N. Wang,et al. T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation. , 2000, Transplantation.
[3] M. Chopek,et al. The extent of HLA class II allele level disparity in unrelated bone marrow transplantation: analysis of 1259 National Marrow Donor Program donor–recipient pairs , 2000, Bone Marrow Transplantation.
[4] Anajane G. Smith,et al. Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation. , 1999, Blood.
[5] J. Hansen,et al. Effect of HLA mismatches on the outcome of hematopoietic transplants. , 1999, Current opinion in immunology.
[6] P. Noris,et al. Incompatibility for CD31 and human platelet antigens and acute graft‐versus‐host disease after bone marrow transplantation , 1999, British journal of haematology.
[7] J. McCluskey,et al. Matching for HLA DPA1 and DPB1 alleles in unrelated bone marrow transplantation. , 1999, Human immunology.
[8] M. Bunce,et al. A DNA-based detection and screening system for identifying HLA class I expression variants by sequence-specific primers. , 1999, Tissue antigens.
[9] G. Heller,et al. HLA-C disparity between patients and unrelated donors matched for HLA-A, -B, and -DRB1 alleles: impact of serological vs. DNA typing for HLA-A and -B loci. , 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[10] M. Maiers,et al. The HLA dictionary 1999: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. , 1999, Human immunology.
[11] I. Joosten,et al. Helper and cytotoxic T cell precursor frequencies are not predictive for development of acute graft-versus-host disease after partially T cell-depleted HLA-identical sibling BMT , 1998, Bone Marrow Transplantation.
[12] Anajane G. Smith,et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. , 1998, Blood.
[13] C Anasetti,et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. , 1998, The New England journal of medicine.
[14] F. Aversa,et al. Use of stem cells from mismatched related donors , 1997, Current opinion in hematology.
[15] G. Longton,et al. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation. , 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[16] N. Schmitz,et al. German consensus on immunogenetic donor search for transplantation of allogeneic bone marrow and peripheral blood stem cells , 1997, Bone Marrow Transplantation.
[17] J. Hansen,et al. Hematopoietic stem cell transplants from unrelated donors , 1997, Immunological reviews.
[18] A. Gratwohl,et al. Haploidentical family member transplants for patients with chronic myeloid leukaemia: a report of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) , 1997, Bone Marrow Transplantation.
[19] R Storb,et al. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. , 1997, Blood.
[20] P. Henslee-Downey,et al. Use of partially mismatched related donors extends access to allogeneic marrow transplant. , 1997, Blood.
[21] E. Goulmy,et al. Minor histocompatibility antigens: from T cell recognition to peptide identification. , 1997, Human immunology.
[22] G. Longton,et al. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. , 1997, Blood.
[23] Loiseau,et al. Does the Adhesion Molecule CD31 Act as a Minor Histocompatibility Antigen? , 1997, Blood.
[24] G. Longton,et al. Definition of HLA-DQ as a transplantation antigen. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[25] D. Speiser,et al. Pretransplant cytotoxic donor T‐cell activity specific to patient HLA class I antigens correlating with mortality after unrelated BMT , 1996, British journal of haematology.
[26] D. Speiser,et al. High resolution HLA matching associated with decreased mortality after unrelated bone marrow transplantation. , 1996, Blood.
[27] H. Sayer,et al. Bone marrow transplantation from partially HLA‐matched related donors in adults with leukaemia: The Experience at the University Hospital of Essen, Germany , 1996, British journal of haematology.
[28] J. Zehnder,et al. Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease. , 1996, The New England journal of medicine.
[29] G. Longton,et al. Evaluation of the mixed lymphocyte culture (MLC) assay as a method for selecting unrelated donors for marrow transplantation. , 1996, Tissue antigens.
[30] G. Longton,et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. , 1995, Blood.
[31] S. Davies,et al. Unrelated donor bone marrow transplantation: influence of HLA A and B incompatibility on outcome. , 1995, Blood.
[32] H. Heimpel,et al. Presence of host-specific interleukin 2-secreting T helper cell precursors correlates closely with active primary and secondary chronic graft-versus-host disease. , 1995, Bone marrow transplantation.
[33] R. Lechler,et al. COMPARISON OF HELPER AND CYTOTOXIC ANTIRECIPIENT T CELL FREQUENCIES IN UNRELATED BONE MARROW TRANSPLANTATION , 1994, Transplantation.
[34] H. Grosse-wilde,et al. Immunogenetic marrow donor search for 1012 patients: a retrospective analysis of strategies, outcome and costs. , 1994, Bone marrow transplantation.
[35] D. Speiser,et al. THE FREQUENCY OF PRETRANSPLANT DONOR CYTOTOXIC T CELL PRECURSORS WITH ANTI‐HOST SPECIFICITY PREDICTS SURVIVAL OF PATIENTS TRANSPLANTED WITH BONE MARROW FROM DONORS OTHER THAN HLA‐IDENTICAL SIBLINGS , 1993, Transplantation.
[36] H. Bontkes,et al. High frequencies of cytotoxic T cell precursors against minor histocompatibility antigens after HLA-identical BMT: absence of correlation with GVHD. , 1993, Bone marrow transplantation.
[37] G. Longton,et al. The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation. , 1993, Blood.
[38] E. Goulmy,et al. Human minor histocompatibility antigens. , 1993, Transplant immunology.
[39] R. Lechler,et al. Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation , 1993, The Lancet.
[40] G. Longton,et al. The Role of HLA-DPB 1 Disparity in the Development of Acute Graft-Versus-Host Disease Following Unrelated Donor Marrow Transplantation , 2003 .
[41] H. Heimpel,et al. Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings. , 1992, The New England journal of medicine.
[42] R. Storb,et al. Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. , 1990, Human immunology.